Insider · CIK 0001640645

O'Neil Thomas P.

Reports to the SEC for 3 companies · DAVIS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001640645

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−60K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−80K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−190K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−72.3K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−76.6K sh	—	—	0
2023-06-06	Satsuma Pharmaceuticals, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−13.9K sh	$0.91	−$12.6K	0
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+190K sh	—	—	190,000
2020-12-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2020-09-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+750 sh	$4.56	+$3,420	750
2020-09-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−750 sh	$22.19	−$16.6K	0
2020-09-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−750 sh	—	—	65,590
2020-08-05	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	1,000
2020-08-05	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,000 sh	$25.00	−$25K	0
2020-08-05	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	66,340
2020-07-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+300 sh	$4.56	+$1,368	300
2020-07-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−300 sh	$25.63	−$7,690.2	0
2020-07-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+394 sh	$4.56	+$1,796.64	394
2020-07-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−394 sh	$26.70	−$10.5K	0
2020-07-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+306 sh	$4.56	+$1,395.36	306
2020-07-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−306 sh	$27.59	−$8,443.642	0
2020-07-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	67,340
2020-06-23	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,115 sh	$1.04	+$2,199.6	2,115
2020-06-23	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,115 sh	$35.23	−$74.5K	0
2020-06-23	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,115 sh	—	—	74,480
2020-06-01	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	1,000
2020-06-01	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,000 sh	$25.32	−$25.3K	0
2020-06-01	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	68,340
2020-05-20	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,000 sh	$4.56	+$9,120	2,000
2020-05-20	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$25.00	−$50K	0
2020-05-20	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,000 sh	—	—	69,340
2020-03-11	Satsuma Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$4.56	+$4,560	1,000
2020-03-11	Satsuma Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,000 sh	$27.68	−$27.7K	0
2020-03-11	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	71,340
2020-03-04	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2018-08-15	PTGXProtagonist Therapeutics, IncA Award	Chief Financial Officer	AAward	+21.1K sh	—	—	30,560
2018-08-15	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+14.1K sh	—	—	14,050
2018-02-28	PTGXProtagonist Therapeutics, IncA Award	Chief Financial Officer	AAward	+6,000 sh	—	—	8,858
2018-02-28	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+34K sh	—	—	34,000
2017-12-18	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,000 sh	$1.16	+$4,640	4,000
2017-12-18	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,000 sh	$4.21	+$16.8K	8,000
2017-12-18	PTGXProtagonist Therapeutics, IncS Sale	Chief Financial Officer	SSale	−8,000 sh	$20.00	−$160K	0
2017-12-18	PTGXProtagonist Therapeutics, Inc · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	57,666
2017-12-18	PTGXProtagonist Therapeutics, Inc · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	28,998
2016-10-11	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000

Recent filings

Accepted (ET)
Jun 84
O'Neil Thomas P.0000899243-23-014901
SEC(opens sec.gov)
Jun 74
O'Neil Thomas P.0001567619-22-012481
SEC(opens sec.gov)
Dec 74
O'Neil Thomas P.0001567619-20-020718
SEC(opens sec.gov)
Sep 34
O'Neil Thomas P.0001567619-20-016411
SEC(opens sec.gov)
Aug 74
O'Neil Thomas P.0001567619-20-014527
SEC(opens sec.gov)
Jul 24
O'Neil Thomas P.0001567619-20-012820
SEC(opens sec.gov)

Companies

Address

C/O ARCADIA BIOSCIENCES, INC. 202 COUSTEAU, SUITE 105

DAVIS, CA, 95618